Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN)
- PMID: 4020139
Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN)
Abstract
Elucidation of the interactions between C5a and granulocytes is central to understanding the role of C5a in inflammation. In this study, interactions between C5a and PMN have been studied at two levels. Binding of human C5a to intact human cells has been characterized by using the radiolabeled ligand 125I-C5a. Binding is shown to be reversible, saturable, and to reach equilibrium in 60 to 90 min at 0 degrees C. Results show high affinity C5a binding sites with Kd = 2 X 10(-9) M and a range of 50,000 to 113,000 binding sites per PMN. These values for C5a receptors are comparable with the number of fMLP and LTB4 receptors on PMN. Binding of C5a to PMN fails to reach equilibrium at 37 degrees C because there is an irreversible loss of available surface receptors caused by an active internalization of the ligand-receptor complex. Interactions between C5a and human PMN were characterized further by cross-linking experiments, with the use of ethylene glycol bis succinimidylsuccinate (EGS). Cross-linking of 125I-C5a to intact PMN followed by subcellular fractionation revealed a single radioactive band present only in the plasma membrane fraction and visualized by autoradiography. Similar experiments resulted in a covalent linkage between 125I-C5a and a component in the isolated plasma membrane of PMN. The covalent complex containing C5a and a putative receptor has been visualized by autoradiography as a single 60,000 Mr complex on SDS-PAGE. The complex is not present when experiments are performed in the presence of excess unlabeled C5a or in the absence of EGS. Therefore, the putative receptor for C5a on human neutrophils is estimated to be approximately 48,000 Mr, assuming contribution of 12,000 to 13,000 daltons by the ligand 125I-C5a.
Similar articles
-
Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.J Immunol. 1986 Sep 15;137(6):1971-6. J Immunol. 1986. PMID: 3018083
-
Cellular receptors to the anaphylatoxins C3a and C5a.Biochem Soc Symp. 1986;51:69-81. Biochem Soc Symp. 1986. PMID: 3545212
-
Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.J Immunol. 1993 Jan 1;150(1):246-52. J Immunol. 1993. PMID: 8417126
-
Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.J Immunol. 1989 Sep 15;143(6):1969-73. J Immunol. 1989. PMID: 2550548
-
Identification of the polymorphonuclear leukocyte C5a receptor.J Biol Chem. 1985 Jun 25;260(12):7157-60. J Biol Chem. 1985. PMID: 3997862
Cited by
-
C5a-induced expression of P-selectin in endothelial cells.J Clin Invest. 1994 Sep;94(3):1147-55. doi: 10.1172/JCI117430. J Clin Invest. 1994. PMID: 7521884 Free PMC article.
-
Variability in G-protein-coupled signaling studied with microfluidic devices.Biophys J. 2010 Oct 20;99(8):2414-22. doi: 10.1016/j.bpj.2010.08.043. Biophys J. 2010. PMID: 20959081 Free PMC article.
-
Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis.Mol Biol Cell. 1999 Apr;10(4):1163-78. doi: 10.1091/mbc.10.4.1163. Mol Biol Cell. 1999. PMID: 10198064 Free PMC article.
-
C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Arthritis Res Ther. 2012 Jun 12;14(3):R140. doi: 10.1186/ar3873. Arthritis Res Ther. 2012. PMID: 22691190 Free PMC article.
-
Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease.J Clin Invest. 1988 May;81(5):1485-96. doi: 10.1172/JCI113480. J Clin Invest. 1988. PMID: 3366903 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous